HKD21.65
7.71% yesterday
Hong Kong, Sep 27, 10:08 am CET
ISIN
KYG549581067
Symbol
3692
Sector
Industry

Hansoh Pharmaceutical Group Company Stock price

HKD21.65
+3.43 18.83% 1M
+6.17 39.86% 6M
+5.89 37.37% YTD
+10.87 100.83% 1Y
+2.69 14.19% 3Y
-1.60 6.88% 5Y
+2.15 11.03% 10Y
Hong Kong, Closing price Fri, Sep 27 2024
+1.55 7.71%
ISIN
KYG549581067
Symbol
3692
Sector
Industry

Key metrics

Market capitalization HKD119.11b
Enterprise Value HKD94.00b
P/E (TTM) P/E ratio 23.34
EV/FCF (TTM) EV/FCF 16.97
EV/Sales (TTM) EV/Sales 7.18
P/S ratio (TTM) P/S ratio 9.10
P/B ratio (TTM) P/B ratio 3.98
Dividend yield 1.71%
Last dividend (FY23) HKD0.34
Revenue growth (TTM) Revenue growth 22.88%
Revenue (TTM) Revenue HKD13.09b
EBIT (operating result TTM) EBIT HKD4.66b
Free Cash Flow (TTM) Free Cash Flow HKD5.30b
EPS (TTM) EPS HKD0.86
P/E forward 26.01
P/S forward 8.95
EV/Sales forward 7.07
Show more

Is Hansoh Pharmaceutical Group Company a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

Hansoh Pharmaceutical Group Company Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Hansoh Pharmaceutical Group Company forecast:

20x Buy
91%
2x Hold
9%

Analyst Opinions

22 Analysts have issued a Hansoh Pharmaceutical Group Company forecast:

Buy
91%
Hold
9%

Financial data from Hansoh Pharmaceutical Group Company

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Jun '24
+/-
%
13,091 13,091
23% 23%
100%
- Direct Costs 1,163 1,163
3% 3%
9%
11,929 11,929
25% 25%
91%
- Selling and Administrative Expenses 4,278 4,278
0% 0%
33%
- Research and Development Expense 2,558 2,558
21% 21%
20%
5,093 5,093
64% 64%
39%
- Depreciation and Amortization 431 431
3% 3%
3%
EBIT (Operating Income) EBIT 4,662 4,662
73% 73%
36%
Net Profit 5,102 5,102
76% 76%
39%

In millions HKD.

Don't miss a Thing! We will send you all news about Hansoh Pharmaceutical Group Company directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. Its products include oncology, anti-infective, anti-diabetic, gastrointestinal, and cardiovascular drugs. The company was founded by Huijuan Zhong on December 2, 2015 and is headquartered in Lianyungang, China.

Head office Cayman Islands
CEO Hui Zhong
Employees 9,123
Founded 2015
Website www.hspharm.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today